Moderna has withdrawn its application to approve the influenza-Covid-19 combination vaccine, intending to resubmit the application with additional data later
Miruna Brosban
Health
sursa foto: pexels.com
Always see our news on Google
The decision follows consultations with the FDA, which has requested new clinical trials for Covid-19 booster doses. Moderna shares fell 1.4% amid declining revenue from Covid-19 vaccines and concerns about the nomination of Robert F. Kennedy Jr. to be secretary of the Health Department. The FDA is expected to decide on the next-generation Covid-19 vaccine, part of the combination vaccine, with no anticipated delays.
Sources
Latest News
23:08
The strong storms in Bihor, Sibiu, and Brașov caused major damage, including torn roofs and fallen trees.
22:19
The Ministry of Energy has notified the European Commission about the severe drought affecting the Danube and the operation of the nuclear power plant in Cernavodă.
21:39
MAE, travel advisory for Japan: Typhoon Dolphin will bring strong gusts of wind and heavy precipitation in Okinawa
21:28
The Romanian team defeated Bulgaria 69-51 in the final quarter of the EuroBasket U18. Romania will play in the semifinals against the winner between Greece and Lithuania.
20:59
Volkswagen: Majority shareholders force a rapid restructuring after a sharp decline in Porsche SE's profit.
See more news
NEWS ON THE SAME TOPICS
.webp)
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
